These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2378175)

  • 1. [Comparison of mid- and high dosage methylprednisolone pulse therapy in chronic polyarthritis].
    Schlumpf U; Hofmann P
    Z Rheumatol; 1990; 49(3):160-4. PubMed ID: 2378175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment with megadoses of dexaven (dexamethasone) versus methypred (6-methylprednisolone) of patients with rheumatoid arthritis].
    Lashina NIu; Solov'ev SK; Balabanova RM
    Ter Arkh; 2000; 72(5):28-31. PubMed ID: 11109615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylprednisolone pulse therapy in conjunction with azathioprine in rheumatoid arthritis.
    Bijlsma JW; Schenk Y; Ramselaar AC; Huber-Bruning O
    Clin Rheumatol; 1986 Dec; 5(4):499-504. PubMed ID: 3816097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
    Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P
    Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prognostic value of Sharp's index in the clinical and laboratory response to an intravenous methylprednisolone pulse in patients with rheumatoid arthritis].
    Cuchacovich M; Gatica H; Muñoz S; González P
    Rev Med Chil; 2000 Mar; 128(3):301-8. PubMed ID: 10962872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulse methylprednisolone in rheumatoid arthritis: effects on peripheral blood and synovial fluid neutrophil surface phenotype.
    Youssef P; Roberts-Thomson P; Ahern M; Smith M
    J Rheumatol; 1995 Nov; 22(11):2065-71. PubMed ID: 8596146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of high dose methylprednisolone pulse therapy on bone mass and biochemical markers of bone metabolism in patients with active rheumatoid arthritis: a 12-month randomized prospective controlled study.
    Frediani B; Falsetti P; Bisogno S; Baldi F; Acciai C; Filippou G; Bacarelli MR; Filipponi P; Galeazzi M; Marcolongo R
    J Rheumatol; 2004 Jun; 31(6):1083-7. PubMed ID: 15170918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of giant cell arteritis using induction therapy with high-dose glucocorticoids: a double-blind, placebo-controlled, randomized prospective clinical trial.
    Mazlumzadeh M; Hunder GG; Easley KA; Calamia KT; Matteson EL; Griffing WL; Younge BR; Weyand CM; Goronzy JJ
    Arthritis Rheum; 2006 Oct; 54(10):3310-8. PubMed ID: 17009270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Side effects and efficiency of 15 mg and 25 mg methotrexate per week in chronic polyarthritis].
    Schnabel A; Reinhold-Keller E; Willmann V; Dihlmann W; Gross WL
    Z Rheumatol; 1994; 53(3):142-9. PubMed ID: 8091868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous pulsed steroids in rheumatoid arthritis: a comparative dose study.
    Iglehart IW; Sutton JD; Bender JC; Shaw RA; Ziminski CM; Holt PA; Hochberg MC; Zizic TM; Engle EW; Stevens MB
    J Rheumatol; 1990 Feb; 17(2):159-62. PubMed ID: 2319516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical effect of glucocorticoids in patients with rheumatoid arthritis may be masked by decreased use of additional therapies.
    van Everdingen AA; Siewertsz van Reesema DR; Jacobs JW; Bijlsma JW
    Arthritis Rheum; 2004 Apr; 51(2):233-8. PubMed ID: 15077265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double blind placebo controlled trial of pulse treatment with methylprednisolone combined with disease modifying drugs in rheumatoid arthritis.
    Hansen TM; Kryger P; Elling H; Haar D; Kreutzfeldt M; Ingeman-Nielsen MW; Olsson AT; Pedersen C; Rahbek A; Tvede N
    BMJ; 1990 Aug; 301(6746):268-70. PubMed ID: 2202458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of pulsed steroid therapy in active rheumatoid arthritis].
    Pavelka K; Honzlová M; Vencovský J
    Cas Lek Cesk; 1992 Oct; 131(19):593-9. PubMed ID: 1464075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [FDDF (fast dissolving dosage form) piroxicam for sublingual administration in the treatment of rheumatoid arthritis].
    Montecucco C; Caporali R; Ronchetti A; Rossi S; Comaschi E
    Minerva Med; 1994 Dec; 85(12):633-8. PubMed ID: 7854556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experience with long term low dose methotrexate treatment in rheumatoid arthritis and arthritic psoriasis].
    Náfrádi L; Varga L
    Orv Hetil; 1995 Jul; 136(29):1555-7. PubMed ID: 7637973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The importance of administration of a series of methylprednisolone minipulses in the treatment of active rheumatoid arthritis].
    Hrncír Z
    Cas Lek Cesk; 1994 Jul; 133(14):440-2. PubMed ID: 8069902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyarticular corticosteroid injection versus systemic administration in treatment of rheumatoid arthritis patients: a randomized controlled study.
    Furtado RN; Oliveira LM; Natour J
    J Rheumatol; 2005 Sep; 32(9):1691-8. PubMed ID: 16142862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Response-driven combination therapy with conventional disease-modifying antirheumatic drugs can achieve high response rates in early rheumatoid arthritis with minimal glucocorticoid and nonsteroidal anti-inflammatory drug use.
    Proudman SM; Keen HI; Stamp LK; Lee AT; Goldblatt F; Ayres OC; Rischmueller M; James MJ; Hill CL; Caughey GE; Cleland LG
    Semin Arthritis Rheum; 2007 Oct; 37(2):99-111. PubMed ID: 17391739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Open label study to assess infliximab safety and timing of onset of clinical benefit among patients with rheumatoid arthritis.
    Shergy WJ; Isern RA; Cooley DA; Harshbarger JL; Huffstutter JE; Hughes GM; Spencer-Smith EA; Goldman AL; Roth SH; Toder JS; Warner D; Quinn A; Keenan GF; Schaible TF;
    J Rheumatol; 2002 Apr; 29(4):667-77. PubMed ID: 11950005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical effectiveness and tolerance of auranofin in patients with chronic polyarthritis. Results of a multicenter long-term study].
    Klein G; Schwann H; Mirtl B; Thumb N; Mayerhofer F; Singer F; Tausch G; Gaismayer K; Rieder H; Hartweger A
    Z Rheumatol; 1988; 47(5):342-6. PubMed ID: 3149087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.